Related Experiment Video
Updated: Oct 14, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Appendicitis as a possible safety signal for the COVID-19 vaccines
Joseph Mitchell1, Qun-Ying Yue1
1Uppsala Monitoring Centre, Bredgränd 7, Uppsala 753 20, Sweden.
Abstract:
This study reviewed cases of appendicitis following administration of COVID-19 vaccines reported to VigiBase, the WHO database of individual case safety reports (ICSRs). Three hundred fifty-eight cases were identified, and disproportionate reporting was noted, with 329 calculated expected cases. Upon review, 24 ICSRs were excluded, so 334 unique ICSRs underwent clinical review from 19 countries. Forty-eight percent of ICSRs reported imaging and 69% noted surgical intervention. The cases were clinically coherent, with an apparent increase in reporting in the four days post-vaccination and a possible dose-response relationship. Appendicitis has been suggested as an adverse event of special interest post-vaccination against COVID-19 after a numerical increase in the vaccine arm of a clinical trial. The case series may be affected by differences in global patterns of reporting, and it is not possible to prove nor disprove causality from this case series. Global longitudinal studies are required to clarify any possible relationship.
Insights
This review of COVID-19 vaccine safety reports found a potential link between vaccination and appendicitis. Further global studies are needed to confirm any causal relationship.
Area of Science:
- Vaccinology
- Gastroenterology
- Pharmacovigilance
Background:
- Appendicitis has been flagged as a potential adverse event following COVID-19 vaccination.
- A numerical increase in appendicitis cases was observed in the vaccine arm of a clinical trial.
Purpose of the Study:
- To investigate reported cases of appendicitis following COVID-19 vaccination.
- To analyze the characteristics and potential associations of these cases.
Main Methods:
- Review of individual case safety reports (ICSRs) submitted to VigiBase (WHO database).
- Inclusion of 334 unique ICSRs from 19 countries after clinical review and exclusion of 24 cases.
- Analysis of reporting patterns, including time to onset, imaging, and surgical intervention.
Main Results:
- Disproportionate reporting of appendicitis cases post-COVID-19 vaccination was noted.
- An apparent increase in reporting within four days post-vaccination and a possible dose-response relationship were observed.
- Forty-eight percent of cases involved imaging, and 69% required surgical intervention.
Conclusions:
- The reviewed cases suggest a potential association between COVID-19 vaccination and appendicitis.
- Causality cannot be established from this case series due to reporting biases.
- Longitudinal global studies are necessary to definitively clarify any relationship between COVID-19 vaccines and appendicitis.
Related Concept Videos
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Myocarditis III: Medical Management
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Aneurysm II: Clinical Manifestations and Diagnostic Studies

